November 1, 2018 7:15pm


Regenerative Medicine Earnings Scorecard - Q3/18 - six (6) to date

Quarterly results - losses with a per shares basis, peer analysis, cash positions, "runways" - how do they measure as compared to "street" expectation?

Do Q3's results indicate pricing performance for Q4 and FY18’s end?    



Why spend time finding and extrapolating quarterly results?

Predictive analytics and  analysis is all right here!


Click on the BUY button:    


Review daily indicators, factors and trend lines, advance/decline lines of 45 covered companies, pre-open indicator results and volatility and of the % count of decliners versus gainers.


My motto: Never leave an investor uninformed!